PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2178969
PUBLISHER: Stratistics Market Research Consulting | PRODUCT CODE: 2178969
According to Stratistics MRC, the Global Spray-Induced Gene Silencing Technology Market is accounted for $0.2 billion in 2026 and is expected to reach $1.1 billion by 2034 growing at a CAGR of 23.8% during the forecast period. Spray-induced gene silencing technology is a non-transgenic crop protection approach in which ribonucleic acid molecules applied externally to plants trigger silencing of genes in attacking pests or pathogens. Exogenous double-stranded RNA, small interfering RNA, and carrier-assisted RNA are absorbed by target organisms and degrade matching messenger RNA, interrupting growth or reproduction. Delivery occurs through foliar spray, trunk injection, seed coating, or soil application. Targets include insect resistance, disease resistance, weed management, and stress tolerance across cereals, horticulture, and plantation crops.
Non-Transgenic Resistance Management
Growing demand for resistance tools that avoid genetic modification is driving interest in spray-induced gene silencing, because the intervention is applied externally and leaves the plant genome unchanged. This distinction simplifies market access in regions where transgenic crops face rejection or labelling requirements. Export markets with strict biotech rules become accessible. The approach supports premium positioning among producers targeting biotech-sensitive destinations, thereby expanding commercial opportunity across horticulture and plantation segments.
RNA Persistence and Delivery Loss
Applied RNA degrades within days under ultraviolet exposure and rainfall, and a large share of the sprayed dose never reaches the target organism. Formulators must increase concentration or add carriers, raising cost per hectare. Uptake efficiency varies by pest species and plant surface. These persistence and delivery losses limit field reliability and confine commercial use to protected environments and high-value crops where repeated application remains economic.
Perennial and Plantation Crops
Perennial and plantation crops create substantial opportunity for spray-induced gene silencing because trunk injection and soil delivery allow repeated controlled exposure to woody tissue where foliar coverage is impractical. Citrus, grape, coffee, and oil palm producers face persistent pathogens with limited chemical options. Injection-based delivery extends RNA persistence compared with surface spray. As delivery hardware matures, plantation applications can capture premium pricing and long-term grower relationships.
Substitution by Conventional Disease Control
Registered fungicides and insecticides remain inexpensive, well understood, and supported by established spray programmes, which reduces willingness to adopt externally applied RNA for routine protection. Many growers perceive conventional chemistry as adequate where resistance is not yet critical. If conventional products retain approval, gene silencing may remain confined to niche high-value situations. Consequently, providers must demonstrate efficacy where chemistry has failed.
The pandemic restricted laboratory access and delayed greenhouse validation while supply constraints affected reagent availability. During the crisis, heightened attention to chemical residues supported interest in biological and non-chemical control approaches. Post-pandemic, restored research capacity and expanding regulatory dialogue on externally applied RNA have reinforced development, while producers advanced delivery platforms and field trial programmes.
The Exogenous dsRNA segment is expected to be the largest during the forecast period
The Exogenous dsRNA segment is expected to account for the largest market share during the forecast period, due to its established silencing efficacy, suitability for spray application, and the maturity of synthesis routes relative to carrier-assisted alternatives. Long double-stranded sequences trigger strong responses across multiple target organisms. As commercial programmes advance, exogenous double-stranded RNA remains the primary approach, thereby sustaining leading revenue share across the category.
The Foliar Spray segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the Foliar Spray segment is predicted to witness the highest growth rate, driven by compatibility with existing spray equipment, low adoption friction for growers, and rapid advancement of formulation adjuvants that extend RNA persistence on leaf surfaces. Foliar application covers large areas quickly without new machinery. As stability improves, foliar programmes accelerate faster than trunk injection, seed coating, and soil delivery platforms.
During the forecast period, the North America region is expected to hold the largest market share, due to advanced research infrastructure, regulatory engagement on externally applied RNA, and grower willingness to trial novel modes of action. The United States dominates regional revenue, supported by specialty crop producers facing resistant pathogens. Strong venture funding for agricultural biotechnology further reinforces the region's leading position.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, due to severe disease pressure in plantation crops, expanding horticulture exports, and growing public research investment across India, China, and Southeast Asia. Local institutions advance delivery technology for citrus and grape systems. Improving technical advisory networks further support adoption, making Asia Pacific the fastest-growing regional market.
Key players in the market
Some of the key players in Spray-Induced Gene Silencing Technology Market include Bayer AG, BASF SE, Syngenta Group, Corteva, Inc., FMC Corporation, UPL Limited, Novonesis A/S, Koppert Biological Systems, Bioceres Crop Solutions Corp., Valent BioSciences LLC, Lallemand Inc., Marrone Bio Innovations, Pivot Bio, Indigo Ag, Ginkgo Bioworks, and Verdesian Life Sciences.
In October 2026, Syngenta Group launched a foliar spray-induced gene silencing product for fungal disease control in grape and vegetable systems, distributed through technical advisory programmes across European and Latin American markets.
In September 2026, Bayer AG expanded its gene silencing portfolio with trunk injection formulations targeting citrus pathogens, deployed through grower cooperatives across North American and Mediterranean production regions.
In August 2026, UPL Limited introduced carrier-assisted RNA formulations for seed coating applications against soil-borne pathogens, distributed through seed treatment partners across Indian and Southeast Asian markets.
North America
United States
Canada
Mexico
Europe
United Kingdom
Germany
France
Italy
Spain
Netherlands
Belgium
Sweden
Switzerland
Poland
Rest of Europe
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Thailand
Malaysia
Singapore
Vietnam
Rest of Asia Pacific
South America
Brazil
Argentina
Colombia
Chile
Peru
Rest of South America
Rest of the World (RoW)
Middle East
Saudi Arabia
United Arab Emirates
Qatar
Israel
Rest of Middle East
Africa
South Africa
Egypt
Morocco
Rest of Africa
Company Profiling
Comprehensive profiling of additional market players (up to 3)
SWOT Analysis of key players (up to 3)
Regional Segmentation
Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
Competitive Benchmarking
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) Regions are also represented in the same manner as above.